EX-23.1
Published on February 23, 2024
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-3 of Benitec Biopharma Inc. (the Company) of our report dated September 21, 2023 relating to the consolidated financial statements of the Company, which appears in the Companys Annual Report on Form 10-K for the year ended June 30, 2023.
We also consent to the reference of our firm under the heading Experts in this Registration Statement.
/s/ BAKER TILLY US, LLP
Mountain View, California
February 23, 2024